Elastase 매개성 폐조직 손상에 대한 선폐정천탕(宣肺定喘湯)의 보호효과

Protective Effects of Seonpyejeongcheon-tang on Elastase-Induced Lung Injury in Mice

  • 윤종만 (대전대학교 한의과대학 폐계내과학교실) ;
  • 박양춘 (대전대학교 한의과대학 폐계내과학교실)
  • Yoon, Jong-Man (Division of Respiratory System, Dept. of Internal Medicine, College of Oriental Medicine, Dae-Jeon University) ;
  • Park, Yang-Chun (Division of Respiratory System, Dept. of Internal Medicine, College of Oriental Medicine, Dae-Jeon University)
  • 발행 : 2010.03.31

초록

Objectives : This study aimed to evaluate the protective effects of Seonpyejeongcheon-tang (SJT) on elastase-induced lung injury. Materials and Methods : The extract of SJT was treated to A549 cells and an elastase-induced lung injury mouse model. Then, various parameters such as cell-based cytoprotective activity and histopathological findings were analyzed. Results : SJT showed a protective effect on elastase-induced cytotoxicity in A549 cells. This effect was correlated with analysis for caspase 3 levels, collagen and elastin contents, protein level of cyclin B 1, Cdk1, and Erk1/2, and gene expression of TNF-$\alpha$ and IL-$1{\beta}$ in A549 cells. SJT treatment also revealed a protective effect on elastase-induced lung injury in mouse model. This effect was evidenced via histopathological findings, including immunofluoresence stains against elastin, collagen, and caspase 3, and protein levels of cyclin B1, Cdc2, and Erk1/2 in lung tissue. Conclusion : These data suggest that SJT has pharmaceutical properties on lung injury. This study thus provides scientific evidence for the efficacy of SJT for clinical application to patients with chronic obstructive pulmonary disease.

키워드

참고문헌

  1. Kim DS, Kim YS, Jung KS, Chang JH, Lim CM, Lee JH, Uh ST, Shim JJ, Lew WJ. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am J Respir Crit Care Med. 2005; 172(7):842-847. https://doi.org/10.1164/rccm.200502-259OC
  2. Korea National Statistical Office. Dajeon: Korea National Statistical Office; c1996-[cited 2009 Mar]. Available from: http://www.nso.go.kr
  3. World Health Report. World Health Organization, Geneva. 2000. Available from URL: http:// www.who.int/whr/2000/en/statistics.htm.
  4. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998;4(11):1241-1243. https://doi.org/10.1038/3218
  5. 장준. 만성 폐쇄성 폐질환의 약물치료. 결핵 및 호흡기질환 2005;59(3):231-242.
  6. 전국한의과대학 폐계내과학교실. 동의폐계내과학. 서울: 한문화사; 2002, p. 338-346.
  7. Lee DJ. The effects of Lonicera japonica on the murine model of Chronic obstructive pulmonary disease. 경희대학교박사학위논문. 2009.
  8. 오지석. 加味八味丸의 elastase 유도성 A549 세포사멸에 대한 보호효과. 대전대학교석사학위논문. 2009.
  9. 허준. 동의보감. 서울: 남산당; 1986, p. 480.
  10. 전국한의과대학 본초학교실. 本草學. 서울: 영림사; 1994, p. 121, 178, 198, 294, 369, 370-373, 448, 453, 460, 463, 478, 482-484, 540, 588, 622.
  11. 정승기, 이형구. 정천탕이 천식에 미치는 영향에 관한 실험적 연구. 경희의학. 1987;3(1):91-102.
  12. 왕중권, 정희재, 정승기, 이형구. The Effects of Jungchun-tang (定喘湯 ) on Respiratory Patterns and Tracheal Tissues in Allergic Asthma. The 10th ICOM 자료집. 1999:102.
  13. 김영우, 정희재, 이용구, 정승기. 정천탕과 청상 보하탕이 asthma model 내의 cytokine에 미치는 영향. 대한한방내과학회지. 2001;22(3):367-377.
  14. 염종훈, 정희재, 정승기, 이형구. 정천탕과 정천탕가감방이 알레르기 천식모델 흰쥐의 BALF 內면역세포 및 혈정 IgE에 미치는 영향. 대한한의학회지. 2003;24(1):169-180.
  15. Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet. 2005;365(9478):2225-2236. https://doi.org/10.1016/S0140-6736(05)66781-5
  16. Churg A, Wright JL. Proteases and emphysema. Curr Opin Pulm Med. 2005;11(2):153-159. https://doi.org/10.1097/01.mcp.0000149592.51761.e3
  17. Foronjy R, D'Armiento J. The role of collagenase in emphysema. Respir Res. 2001;2(6):348-352. https://doi.org/10.1186/rr85
  18. 김현국, 이상도. 만성폐쇄성폐질환의 병태생리. 결핵 및 호흡기질환. 2005;59(1):5-13.
  19. Hantos Z, Adamicza A, Janosi TZ, Szabari MV, Tolnai J, Suki B. Lung volumes and respiratory mechanics in elastase-induced emphysema in mice. J Appl Physiol. 2008;105(6):1864-1872. https://doi.org/10.1152/japplphysiol.90924.2008
  20. Kawakami M, Matsuo Y, Yoshiura K, Nagase T, Yamashita N. Sequential and quantitative analysis of a murine model of elastase-induced emphysema. Biol Pharm Bull. 2008;31(7):1434-1438. https://doi.org/10.1248/bpb.31.1434
  21. Nakajoh M, Fukushima T, Suzuki T, Yamaya M, Nakayama K, Sekizawa K, Sasaki H. Retinoic acid inhibits elastase-induced injury in human lung epithelial cell lines. Am J Respir Cell Mol Biol. 2003;28(3):296-304. https://doi.org/10.1165/rcmb.4845
  22. Lucey EC, Goldstein RH, Stone PJ, Snider GL. Remodeling of alveolar walls after elastase treatment of hamsters. Results of elastin and collagen mRNA in situ hybridization. Am J Respir Crit Care Med. 1998;158(2):555-564. https://doi.org/10.1164/ajrccm.158.2.9705021
  23. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001 ;163(5):1256-1276.
  24. Tremblay GM, Janelle MF, Bourbonnais Y. Anti-inflammatory activity of neutrophil elastase inhibitors. Curr Opin Investig Drugs. 2003; 4(5):556-565.
  25. Lungarella G, Cavarra E, Lucattelli M, Martorana PA. The dual role of neutrophil elastase in lung destruction and repair. Int J Biochem Cell Biol. 2008;40:1287-1296. https://doi.org/10.1016/j.biocel.2007.12.008
  26. Gardi C, Arezzini B, Martorana PA. Testing of compounds in models of pulmonary emphysema. Curr Med Chem. 2008;15(8):803-808. https://doi.org/10.2174/092986708783955536
  27. Grutter MG. Caspases: key players in programmed cell death. Curr Opin Struct Biol. 2000;10(6) :649-655. https://doi.org/10.1016/S0959-440X(00)00146-9
  28. Uhal BD. Cell cycle kinetics in the alveolar epithelium. Am J Physiol. 1997;272:L1031-L1045.
  29. Draetta G. Cell cycle control in eukaryotes: molecular mechanisms of cdc2 activation. Trends Biochem Sci. 1990;15(10):378-383. https://doi.org/10.1016/0968-0004(90)90235-4
  30. Nigg EA, Krek W, Peter M. Vertebrate cdc2 kinase: its regulation by phosphorylation and its mitotic targets. Cold Spring Harb Symp Quant Biol. 1991;56:539-547. https://doi.org/10.1101/SQB.1991.056.01.061
  31. Enoch T, Nurse P. Coupling M phase and S phase: controls maintaining the dependence of mitosis on chromosome replication. Cell. 1991; 65(6):921-923. https://doi.org/10.1016/0092-8674(91)90542-7
  32. Tsai LH, Harlow E, Meyerson M. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase. Nature. 1991;353(6340):174-177. https://doi.org/10.1038/353174a0
  33. Goga A, Yang D, Tward AD, Morgan DO, Bishop JM. Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC. Nat Med. 2007;13(7):820-827. https://doi.org/10.1038/nm1606
  34. Manes T, Zheng DQ, Tognin S, Woodard AS, Marchisio PC, Languino LR. Alpha(v)beta3 integrin expression up-regulates cdc2, which modulates cell migration. J Cell Biol. 2003; 161(4):817-826. https://doi.org/10.1083/jcb.200212172
  35. Segal RA, Greenberg ME. Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci. 1996;19:463-489. https://doi.org/10.1146/annurev.ne.19.030196.002335
  36. Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med. 1996;74(10):589-607. https://doi.org/10.1007/s001090050063
  37. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995;270(5240):1326-1331.
  38. Ligeza A, Wawrzczak-Bargiela A, Kaminska D, Korostynski M, Przewlocki R. Regulation of ERK1/2 phosphorylation by acute and chronic morphine - implications for the role of cAMP-responsive element binding factor (CREB) -dependent and Ets-like protein-1 (Elk-1) -dependent transcription; small interfering RNA -based strategy. FEBS J. 2008;275(15):3836-3849. https://doi.org/10.1111/j.1742-4658.2008.06531.x
  39. Cavanaugh KJ Jr, Oswari J, Margulies SS. Role of stretch on tight junction structure in alveolar epithelial cells. Am J Respir Cell Mol Biol. 2001;25(5):584-591. https://doi.org/10.1165/ajrcmb.25.5.4486